Clinical Trial Update: Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the anti-anginal effects of T89 in chronic stable angina patients. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina Pectoris

Drugs mentioned

• T89

Snippet

Sponsor: Tasly Pharmaceuticals, Inc. | Conditions: Chronic Stable Angina Pectoris | Phase 3 | Status: RECRUITING